QA: Artelo Biosciences INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2026_Artelo_Biosciences_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001621221, Artelo Biosciences INC

  xvar xval
0 AssetsCurrent 695,000
1 IntangibleAssetsNetIncludingGoodwill 2,039,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 67,000
4 LiabilitiesCurrent 4,044,000
5 LiabilitiesNoncurrent 29,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,104,479
9 ResearchAndDevelopmentExpense 5,361,184
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,537,065
13 remainder_ComprehensiveNetIncome -54,369
  yvar yval
0 Assets 2,801,000
1 Liabilities 4,073,000
2 Expenses 12,465,663
3 Revenues 0
4 StockholdersEquity -1,272,000
5 NetIncome -14,002,728
6 ComprehensiveNetIncome -14,029,912
7 BaseVar 10,465,548
8 EconomicCapitalRatiobeforeLimitedLiability -4.89
9 EconomicCapitalRatio 0.208

Edgar->Model Mapping

Feature Distribution

Change over Time